262 related articles for article (PubMed ID: 9459568)
1. [3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor.
Wainscott DB; Sasso DA; Kursar JD; Baez M; Lucaites VL; Nelson DL
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):17-24. PubMed ID: 9459568
[TBL] [Abstract][Full Text] [Related]
2. High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes.
Convents A; Convents D; De Backer JP; De Keyser J; Vauquelin G
Biochem Pharmacol; 1989 Feb; 38(3):455-63. PubMed ID: 2563652
[TBL] [Abstract][Full Text] [Related]
3. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
Wright IK; Blaylock NA; Kendall DA; Wilson VG
Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
[TBL] [Abstract][Full Text] [Related]
4. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD
J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
[TBL] [Abstract][Full Text] [Related]
5. [3H]rauwolscine behaves as an agonist for the 5-HT1A receptors in human frontal cortex membranes.
De Vos H; Czerwiec E; De Backer JP; De Potter W; Vauquelin G
Eur J Pharmacol; 1991 May; 207(1):1-8. PubMed ID: 1680719
[TBL] [Abstract][Full Text] [Related]
6. Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines.
Erdbrügger W; Raulf M; Otto T; Michel MC
J Pharmacol Exp Ther; 1995 Jun; 273(3):1287-94. PubMed ID: 7791100
[TBL] [Abstract][Full Text] [Related]
7. Characterization of binding sites for [3H]-idazoxan, [3H]-P-aminoclonidine and [3H]-rauwolscine in the kidney of the dog.
Evans RG; Haynes JM
Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):649-58. PubMed ID: 7813124
[TBL] [Abstract][Full Text] [Related]
8. Characterization of [3H]rauwolscine binding to alpha 2-adrenoceptor sites in the lumbar spinal cord of the cat: comparison to such binding sites in the cat frontal cerebral cortex.
Howe JR; Yaksh TL
Brain Res; 1986 Mar; 368(1):87-100. PubMed ID: 2869820
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
Brüss M; Molderings GJ; Bönisch H; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
[TBL] [Abstract][Full Text] [Related]
10. Characterization of alpha 2-adrenergic receptors of calf retina membranes by [3H]-rauwolscine and [3H]-RX 781094 binding.
Convents A; De Backer JP; Vauquelin G
Biochem Pharmacol; 1987 Aug; 36(15):2497-503. PubMed ID: 3038126
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
Molderings GJ; Likungu J; Jakschik J; Göthert M
Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
[TBL] [Abstract][Full Text] [Related]
12. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
[TBL] [Abstract][Full Text] [Related]
13. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
[TBL] [Abstract][Full Text] [Related]
14. [3H]rauwolscine (alpha-yohimbine): a specific antagonist radioligand for brain alpha 2-adrenergic receptors.
Perry BD; U'Prichard DC
Eur J Pharmacol; 1981 Dec; 76(4):461-4. PubMed ID: 6276200
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
Khawaja X; Ennis C; Minchin MC
Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
[TBL] [Abstract][Full Text] [Related]
17. Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenylyl cyclase by recombinant human 5-HT1A receptors.
Arthur JM; Casañas SJ; Raymond JR
Biochem Pharmacol; 1993 Jun; 45(11):2337-41. PubMed ID: 8517875
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497
[TBL] [Abstract][Full Text] [Related]
19. [3H]-RS-15385-197, a selective and high affinity radioligand for alpha 2-adrenoceptors: implications for receptor classification.
MacKinnon AC; Kilpatrick AT; Kenny BA; Spedding M; Brown CM
Br J Pharmacol; 1992 Aug; 106(4):1011-8. PubMed ID: 1327384
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of (10bS)-1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinoline oxalate (YSL-3S) as a new alpha2-adrenoceptor antagonist.
Chung SH; Yook J; Min BJ; Lee JY; Lee YS; Jin C
Arch Pharm Res; 2000 Aug; 23(4):353-9. PubMed ID: 10976583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]